160 related articles for article (PubMed ID: 23583574)
21. Role of 5-HT1B/D receptors in canine gastric accommodation: effect of sumatriptan and 5-HT1B/D receptor antagonists.
De Ponti F; Crema F; Moro E; Nardelli G; Frigo G; Crema A
Am J Physiol Gastrointest Liver Physiol; 2003 Jul; 285(1):G96-104. PubMed ID: 12646419
[TBL] [Abstract][Full Text] [Related]
22. Investigation of the role of 5-HT1B and 5-HT1D receptors in the sumatriptan-induced constriction of porcine carotid arteriovenous anastomoses.
De Vries P; Willems EW; Heiligers JP; Villalón CM; Saxena PR
Br J Pharmacol; 1999 May; 127(2):405-12. PubMed ID: 10385240
[TBL] [Abstract][Full Text] [Related]
23. Formalin-induced long-term secondary allodynia and hyperalgesia are maintained by descending facilitation.
Ambriz-Tututi M; Cruz SL; Urquiza-Marín H; Granados-Soto V
Pharmacol Biochem Behav; 2011 May; 98(3):417-24. PubMed ID: 21334366
[TBL] [Abstract][Full Text] [Related]
24. Spinal sumatriptan inhibits capsaicin-induced canine external carotid vasodilatation via 5-HT1B rather than 5-HT1D receptors.
Muñoz-Islas E; Lozano-Cuenca J; González-Hernández A; Ramírez-Rosas MB; Sánchez-López A; Centurión D; Maassenvandenbrink A; Villalón CM
Eur J Pharmacol; 2009 Aug; 615(1-3):133-8. PubMed ID: 19460365
[TBL] [Abstract][Full Text] [Related]
25. Toluene exposure enhances acute and chronic formalin-induced nociception in rats: Participation of 5-HT
Cervantes-Durán C; Ortega-Varela LF; Godínez-Hernández D; Granados-Soto V; Gauthereau-Torres MY
Neurotoxicology; 2017 Dec; 63():97-105. PubMed ID: 28947236
[TBL] [Abstract][Full Text] [Related]
26. Role of peripheral 5-HT
Nascimento EB; Romero TRL; Dutra MMGB; Fiebich BL; Duarte IDG; Coelho MM
Biomed Pharmacother; 2021 Mar; 135():111210. PubMed ID: 33453675
[TBL] [Abstract][Full Text] [Related]
27. Role of peripheral and spinal 5-HT6 receptors according to the rat formalin test.
Castañeda-Corral G; Rocha-González HI; Araiza-Saldaña CI; Ambriz-Tututi M; Vidal-Cantú GC; Granados-Soto V
Neuroscience; 2009 Aug; 162(2):444-52. PubMed ID: 19422883
[TBL] [Abstract][Full Text] [Related]
28. Role of TRPV1 and ASIC3 in formalin-induced secondary allodynia and hyperalgesia.
Martínez-Rojas VA; Barragán-Iglesias P; Rocha-González HI; Murbartián J; Granados-Soto V
Pharmacol Rep; 2014 Dec; 66(6):964-71. PubMed ID: 25443722
[TBL] [Abstract][Full Text] [Related]
29. Pronociceptive role of peripheral and spinal 5-HT7 receptors in the formalin test.
Rocha-González HI; Meneses A; Carlton SM; Granados-Soto V
Pain; 2005 Sep; 117(1-2):182-92. PubMed ID: 16098671
[TBL] [Abstract][Full Text] [Related]
30. Serotonin induces peripheral mechanical antihyperalgesic effects in mice.
Diniz DA; Petrocchi JA; Navarro LC; Souza TC; Castor MG; Perez AC; Duarte ID; Romero TR
Eur J Pharmacol; 2015 Nov; 767():94-7. PubMed ID: 26460149
[TBL] [Abstract][Full Text] [Related]
31. Endogenous descending facilitation and inhibition differ in control of formalin intramuscularly induced persistent muscle nociception.
Lei J; You HJ
Exp Neurol; 2013 Oct; 248():100-11. PubMed ID: 23756144
[TBL] [Abstract][Full Text] [Related]
32. Role of glutamate receptors in the dorsal reticular nucleus in formalin-induced secondary allodynia.
Ambriz-Tututi M; Palomero-Rivero M; Ramirez-López F; Millán-Aldaco D; Drucker-Colín AR
Eur J Neurosci; 2013 Oct; 38(7):3008-17. PubMed ID: 23869620
[TBL] [Abstract][Full Text] [Related]
33. Antihyperalgesic activity of a novel synthesized analogue of lidocaine in diabetic rats.
García-Hernández L; Navarrete-Vázquez G; González-Trujano ME; López-Muñoz FJ; Déciga-Campos M
J Pharm Pharmacol; 2013 May; 65(5):689-96. PubMed ID: 23600386
[TBL] [Abstract][Full Text] [Related]
34. Antinociceptive, antiallodynic and antihyperalgesic effects of the 5-HT
Sałat K; Kołaczkowski M; Furgała A; Rojek A; Śniecikowska J; Varney MA; Newman-Tancredi A
Neuropharmacology; 2017 Oct; 125():181-188. PubMed ID: 28751195
[TBL] [Abstract][Full Text] [Related]
35. Melatonin reduces formalin-induced nociception and tactile allodynia in diabetic rats.
Arreola-Espino R; Urquiza-Marín H; Ambriz-Tututi M; Araiza-Saldaña CI; Caram-Salas NL; Rocha-González HI; Mixcoatl-Zecuatl T; Granados-Soto V
Eur J Pharmacol; 2007 Dec; 577(1-3):203-10. PubMed ID: 17920585
[TBL] [Abstract][Full Text] [Related]
36. Role of opioid receptors in the reduction of formalin-induced secondary allodynia and hyperalgesia in rats.
Ambriz-Tututi M; Rocha-González HI; Castañeda-Corral G; Araiza-Saldaña CI; Caram-Salas NL; Cruz SL; Granados-Soto V
Eur J Pharmacol; 2009 Oct; 619(1-3):25-32. PubMed ID: 19686723
[TBL] [Abstract][Full Text] [Related]
37. Role of spinal 5-HT2 receptors subtypes in formalin-induced long-lasting hypersensitivity.
Cervantes-Durán C; Vidal-Cantú GC; Godínez-Chaparro B; Granados-Soto V
Pharmacol Rep; 2016 Apr; 68(2):434-42. PubMed ID: 26922550
[TBL] [Abstract][Full Text] [Related]
38. Marked sexual dimorphism in 5-HT
Araldi D; Ferrari LF; Green P; Levine JD
Neuroscience; 2017 Mar; 344():394-405. PubMed ID: 28040566
[TBL] [Abstract][Full Text] [Related]
39. The potential role of serotonergic mechanisms in the spinal oxytocin-induced antinociception.
Godínez-Chaparro B; Martínez-Lorenzana G; Rodríguez-Jiménez J; Manzano-García A; Rojas-Piloni G; Condés-Lara M; González-Hernández A
Neuropeptides; 2016 Dec; 60():51-60. PubMed ID: 27449278
[TBL] [Abstract][Full Text] [Related]
40. Pharmacological diversity between native human 5-HT1B and 5-HT1D receptors sited on different neurons and involved in different functions.
Marcoli M; Maura G; Munari C; Ruelle A; Raiteri M
Br J Pharmacol; 1999 Feb; 126(3):607-12. PubMed ID: 10188970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]